Replies to post #247018 on Biotech Values

[DewDiligence]

…20-30-40 year maturities is a puzzle to me.....what's your take?

The buyers of these tranches are presumably life-insurance companies and pension funds, who can match the long duration of the bonds to their long-duration actuarial liabilities, thereby neutralizing the interest rate risk.